Actonel (Risedronate) for Osteoporosis: Uses, Dosing, Side Effects & Monitoring
Risedronate (Actonel) is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption, increasing bone mineral density and reducing vertebral, non-vertebral, and hip fracture risk.
Indications
- Postmenopausal osteoporosis (treatment/prevention).
- Glucocorticoid-induced osteoporosis.
- Paget's disease of bone.
- Osteoporosis in men.
Dosing Regimens
- 5 mg daily or 35 mg weekly (osteoporosis).
- 150 mg monthly (osteoporosis).
- 30 mg daily × 2 months (Paget's).
Critical Administration Rules
- Take on empty stomach with 6–8 oz plain water.
- Remain upright ≥30 min; no food, drink, or other meds.
- Supplement calcium/vitamin D if dietary intake insufficient.
Common Side Effects
- GI: Heartburn, esophagitis, nausea, abdominal pain.
- Musculoskeletal: Bone/joint/muscle pain.
- Rare: Atypical femoral fracture, osteonecrosis of jaw (ONJ), uveitis/scleritis.
Monitoring
DEXA at 1–2 year intervals; renal function (contraindicated if CrCl <30 mL/min); dental exam before starting; report thigh/groin pain (atypical fracture warning).
Osteoporosis - Related Articles
- Osteoporosis and Pain: Understanding the Connection
- Osteoporosis Exercise: Strengthening Bones & Improving Strength
- Bone Density Scans: Understanding Osteoporosis Screening
- Osteoporosis Facts vs. Myths: Prevention & Risk Factors
- Protect Your Bones: Minimizing Osteoporosis Risk Factors
- Osteoporosis Supplements: They Support—They Don't Cure
- Osteoporosis Pain Solutions: Relief & Management Strategies
